Cargando…

Optimality criteria for futility stopping boundaries for group sequential designs with a continuous endpoint

BACKGROUND: In clinical trials with fixed study designs, statistical inference is only made when the trial is completed. In contrast, group sequential designs allow an early stopping of the trial at interim, either for efficacy when the treatment effect is significant or for futility when the treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xieran, Herrmann, Carolin, Rauch, Geraldine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643306/
https://www.ncbi.nlm.nih.gov/pubmed/33153438
http://dx.doi.org/10.1186/s12874-020-01141-5
_version_ 1783606252780126208
author Li, Xieran
Herrmann, Carolin
Rauch, Geraldine
author_facet Li, Xieran
Herrmann, Carolin
Rauch, Geraldine
author_sort Li, Xieran
collection PubMed
description BACKGROUND: In clinical trials with fixed study designs, statistical inference is only made when the trial is completed. In contrast, group sequential designs allow an early stopping of the trial at interim, either for efficacy when the treatment effect is significant or for futility when the treatment effect seems too small to justify a continuation of the trial. Efficacy stopping boundaries based on alpha spending functions have been widely discussed in the statistical literature, and there is also solid work on the choice of adequate futility stopping boundaries. Still, futility boundaries are often chosen with little or completely without theoretical justification, in particular in investigator initiated trails. Some authors contributed to fill this gap. In here, we rely on an idea of Schüler et al. (2017) who discuss optimality criteria for futility boundaries for the special case of trials with (multiple) time-to-event endpoints. Their concept can be adopted to define “optimal” futility boundaries (with respect to given performance indicators) for continuous endpoints. METHODS: We extend Schülers’ definition for “optimal” futility boundaries to the most common study situation of a single continuous primary endpoint compared between two groups. First, we introduce the analytic algorithm to derive these futility boundaries. Second, the new concept is applied to a real clinical trial example. Finally, the performance of a study design with an “optimal” futility boundary is compared to designs with arbitrarily chosen futility boundaries. RESULTS: The presented concept of deriving futility boundaries allows to control the probability of wrongly stopping for futility, that means stopping for futility even if the treatment effect is promizing. At the same time, the loss in power is also controlled by this approach. Moreover, “optimal” futility boundaries improve the probability of correctly stopping for futility under the null hypothesis of no difference between two groups. CONCLUSIONS: The choice of futility boundaries should be thoroughly investigated at the planning stage. The sometimes met, arbitrary choice of futility boundaries can lead to a substantial negative impact on performance. Applying futility boundaries with predefined optimization criteria increases efficiency of group sequential designs. Other optimization criteria than proposed in here might be incorporated. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at (doi:10.1186/s12874-020-01141-5).
format Online
Article
Text
id pubmed-7643306
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-76433062020-11-05 Optimality criteria for futility stopping boundaries for group sequential designs with a continuous endpoint Li, Xieran Herrmann, Carolin Rauch, Geraldine BMC Med Res Methodol Research Article BACKGROUND: In clinical trials with fixed study designs, statistical inference is only made when the trial is completed. In contrast, group sequential designs allow an early stopping of the trial at interim, either for efficacy when the treatment effect is significant or for futility when the treatment effect seems too small to justify a continuation of the trial. Efficacy stopping boundaries based on alpha spending functions have been widely discussed in the statistical literature, and there is also solid work on the choice of adequate futility stopping boundaries. Still, futility boundaries are often chosen with little or completely without theoretical justification, in particular in investigator initiated trails. Some authors contributed to fill this gap. In here, we rely on an idea of Schüler et al. (2017) who discuss optimality criteria for futility boundaries for the special case of trials with (multiple) time-to-event endpoints. Their concept can be adopted to define “optimal” futility boundaries (with respect to given performance indicators) for continuous endpoints. METHODS: We extend Schülers’ definition for “optimal” futility boundaries to the most common study situation of a single continuous primary endpoint compared between two groups. First, we introduce the analytic algorithm to derive these futility boundaries. Second, the new concept is applied to a real clinical trial example. Finally, the performance of a study design with an “optimal” futility boundary is compared to designs with arbitrarily chosen futility boundaries. RESULTS: The presented concept of deriving futility boundaries allows to control the probability of wrongly stopping for futility, that means stopping for futility even if the treatment effect is promizing. At the same time, the loss in power is also controlled by this approach. Moreover, “optimal” futility boundaries improve the probability of correctly stopping for futility under the null hypothesis of no difference between two groups. CONCLUSIONS: The choice of futility boundaries should be thoroughly investigated at the planning stage. The sometimes met, arbitrary choice of futility boundaries can lead to a substantial negative impact on performance. Applying futility boundaries with predefined optimization criteria increases efficiency of group sequential designs. Other optimization criteria than proposed in here might be incorporated. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at (doi:10.1186/s12874-020-01141-5). BioMed Central 2020-11-05 /pmc/articles/PMC7643306/ /pubmed/33153438 http://dx.doi.org/10.1186/s12874-020-01141-5 Text en © The Author(s) 2020 , corrected publication [2020]. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visithttp://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Li, Xieran
Herrmann, Carolin
Rauch, Geraldine
Optimality criteria for futility stopping boundaries for group sequential designs with a continuous endpoint
title Optimality criteria for futility stopping boundaries for group sequential designs with a continuous endpoint
title_full Optimality criteria for futility stopping boundaries for group sequential designs with a continuous endpoint
title_fullStr Optimality criteria for futility stopping boundaries for group sequential designs with a continuous endpoint
title_full_unstemmed Optimality criteria for futility stopping boundaries for group sequential designs with a continuous endpoint
title_short Optimality criteria for futility stopping boundaries for group sequential designs with a continuous endpoint
title_sort optimality criteria for futility stopping boundaries for group sequential designs with a continuous endpoint
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643306/
https://www.ncbi.nlm.nih.gov/pubmed/33153438
http://dx.doi.org/10.1186/s12874-020-01141-5
work_keys_str_mv AT lixieran optimalitycriteriaforfutilitystoppingboundariesforgroupsequentialdesignswithacontinuousendpoint
AT herrmanncarolin optimalitycriteriaforfutilitystoppingboundariesforgroupsequentialdesignswithacontinuousendpoint
AT rauchgeraldine optimalitycriteriaforfutilitystoppingboundariesforgroupsequentialdesignswithacontinuousendpoint